| Sales | 5,130a | 6,024a |
| Of which revenue from non-core activities | 590a | 1,145a |
| Of which net sales | 4,540a | 4,880a |
| Cost of goods sold | -3,984a | -4,642a |
| Gross margin | 1,146a | 1,382a |
| Commercial costs | -93a | -100a |
| Administrative costs | -326a | -426a |
| Research and development costs | -34a | -47a |
| Other operating gains and (losses) | -91a | 15a |
| Earnings from associates and joint ventures | 38a | 53a |
| Results from portfolio management and major restructuring | -134a | -550a |
| Results from legacy remediation and major litigations | -73a | -50a |
| EBIT | 433a | 278a |
| Cost of borrowings | -108a | -71a |
| Interest on loans and short term deposits | 17a | 36a |
| Other gains and (losses) on net indebtedness | 15a | -6a |
| Cost of discounting provisions | -15a | -62a |
| Result from equity instruments measured at fair value | -22a | 4a |
| Profit/(loss) for the year before taxes | 320a | 180a |
| Income taxes | -87a | -208a |
| Profit/(loss) for the year from continuing operations | 233a | -28a |
| Profit for the year from discontinued operations | 0a | 2,132a |
| Profit/(loss) for the year | 233a | 2,105a |
| Attributable to | — | — |
| Solvay share - continuing operations | 223a | -37a |
| Solvay share - discontinued operations | 0a | 2,130a |
| Non-controlling interests - continuing operations | 10a | 9a |
| Non-controlling interests - discontinued operations | 0a | 2a |